Mecuris

Mecuris enables the individual and custom-made production of orthopaedic aids by means of an intuitive web-based platform and subsequent manufacturing using 3D printing. This includes orthoses (e.g. for stabilising the cervical spine) and prostheses (e.g. artificial limbs), as well as equipment such as covers for below-knee prostheses. Mecuris not only provides orthopaedic clinics and medical supply stores with its innovative platform, but also with a full service package right up to delivery of the manufactured products. Design data is adjusted to a patient’s anatomy in an automated fashion based on digital patient data (CT, scanning, photos).

Press releases

Press
13. January 2020
A successful start into the new year: New Growth Funding for MedTech Company Mecuris GmbH
German med-tech company Mecuris GmbH has successfully concluded a new funding round amounting to 3.6 million euros. In addition to the seed investors Bayern Kapital and High-Tech Gründerfonds (HTGF), the international investment company Mulcan, life science venture capital investor Vesalius Biocapital, and Sana Kliniken AG, one of the top five hospital chains in Germany, are once again also on board. Clear yes from the O&P industry to digitalization The Munich-based start-up has set out to
 
Press
16. January 2019
Series-A Investment for Munich-based Medical Technology Startup Mecuris
Mecuris GmbH, a commercial-stage Munich-based medical technology startup focusing on the digitalization of prosthetics and orthotics, successfully completes its Series-A financing round of EUR 3.6m. In addition to existing seed investors Bayern Kapital and High-Tech Gründerfonds (HTGF), the new investors Vesalius Biocapital, Mulcan International Investments and one of the Top 5 hospital chains in Germany support now the innovative Mecuris approach. Every patient is unique! Therefore, the dem
 
Press
21. November 2016
Mecuris GmbH secures seed financing for enabling digital prosthetics and orthotics
High-Tech Gründerfonds (HTGF), together with Bayern Kapital, is investing in Munich-based medical technology startup Mecuris. Specialising in personalised and additively manufactured orthopaedic patient aids, Mecuris offers an innovative solution platform for hospitals and medical supply stores. The latest financing will be used to expand the platform and develop additional applications. Orthopaedic technology continues to be a largely manual, craft-based trade, even in times of increasing d
 

Info & Contact

Wolf-Peter Werner
Web:
mecuris.com

Address

Mecuris GmbH
Ligsalzstr 33.
80339 München

In portfolio

27. Oct 2016

HTGF Manager

 
Dr. Frank Hensel, Principal / Authorized signatory